J Le Pavec Selected Research

Brain Natriuretic Peptide (Natrecor)

1/2010

Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Le Pavec Research Topics

Disease

4	Pulmonary Arterial Hypertension 01/2010 - 12/2006
3	Pulmonary Hypertension 01/2010 - 04/2007
2	COVID-19 11/2020 - 05/2020
2	Disease Progression 01/2018 - 02/2008
1	Post-Acute COVID-19 Syndrome 03/2022
1	Pulmonary Aspergillosis 01/2017
1	Lung Neoplasms (Lung Cancer) 04/2016
1	Melanoma (Melanoma, Malignant) 04/2016
1	Systemic Scleroderma (Systemic Sclerosis) 01/2010
1	Fibrosis (Cirrhosis) 09/2009
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 09/2009
1	HIV Infections (HIV Infection) 01/2009
1	Familial Primary Pulmonary Hypertension 02/2008

Drug/Important Bio-Agent (IBA)

2	Monoclonal AntibodiesIBA 01/2017 - 04/2016
1	Immunoglobulin G (IgG)IBA 03/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2017
1	Immune Checkpoint ProteinsIBA 04/2016
1	pro-brain natriuretic peptide (1-76)IBA 01/2010
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2010
1	MonocrotalineIBA 09/2009
1	Bosentan (Tracleer)FDA Link 01/2009
1	FenfluramineIBA 02/2008
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 12/2006

Therapy/Procedure

4	Therapeutics 01/2017 - 12/2006
2	Lung Transplantation 11/2020 - 05/2020
1	Immunotherapy 01/2018
1	Ligation 09/2009
1	Highly Active Antiretroviral Therapy (HAART) 01/2009